Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Publisher
    • Source
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
777 result(s) for "Psychosocial Support Systems"
Sort by:
Lives interrupted : psychiatric narratives of struggle and resilience
\"Based on interviews with individuals who struggle with severe psychic distress, contributors to this edited collection critique conventional pharmaceutical and medicalized treatment and argue for the need to create facilitative spaces in which psychosocial and familial supports are offered as adjuncts to therapy\"-- Provided by publisher.
Beyond PTSD
Impulsivity, poor judgment, moodiness, risky behavior. \"You don't understand.\" \"I don't care.\" \"Whatever, bro.\" Engaging and working with teenagers is tough. Typically, we attribute this to the storms of adolescence. But what if some of the particularly problematic behaviors we see in teens -- self-destructive behaviors, academic issues, substance abuse, reluctance to engage in therapy or treatment -- point to unspoken trauma? Teens nationwide struggle with traumatic stress related to poverty, abuse, neglect, bullying, traumatic loss, and interpersonal or community violence. But youth are also generally reluctant to disclose or discuss experiences of traumatic stress, and adults working with these youth may not immediately perceive the connection between prior trauma and the teen's current risky or concerning behavior. Beyond PTSD: Helping and Healing Teens Exposed to Trauma helps adults recognize and understand traumatized youth, and provides concrete strategies for talking to and engaging the teen, overcoming resistance, and finding the most appropriate evidence-based treatment approach for them. Nearly twenty contributors pull from their extensive and varied experience working in schools and hospitals to child welfare programs, juvenile justice facilities, pediatric offices, and with families to provide concrete tips to manage the challenges and opportunities of working with trauma-exposed adolescents. Chapters present trauma-informed approaches to youth with aggression, suicide and self-injury, psychosis, and school refusal; youth with physical or developmental disabilities or medical comorbidities, those in juvenile justice or child welfare; teen parents; and LGBTQ youth, among others. Throughout the text, tables compare different types of trauma therapies and provide information about how treatments might be adapted to fit a specific teen or setting. Readers will also find \"real life\" case vignettes and concrete, specific clinical pearls -- even examples of language to use -- to demonstrate how to work effectively with difficult-to-engage teens with complex symptoms and behaviors. Written to be practical and accessible for clinicians, social workers, pediatricians, school counselors, and even parents, with the information, context, and strategies they need to help the teen in front of them.
A national experiment reveals where a growth mindset improves achievement
A global priority for the behavioural sciences is to develop cost-effective, scalable interventions that could improve the academic outcomes of adolescents at a population level, but no such interventions have so far been evaluated in a population-generalizable sample. Here we show that a short (less than one hour), online growth mindset intervention—which teaches that intellectual abilities can be developed—improved grades among lower-achieving students and increased overall enrolment to advanced mathematics courses in a nationally representative sample of students in secondary education in the United States. Notably, the study identified school contexts that sustained the effects of the growth mindset intervention: the intervention changed grades when peer norms aligned with the messages of the intervention. Confidence in the conclusions of this study comes from independent data collection and processing, pre-registration of analyses, and corroboration of results by a blinded Bayesian analysis. A US national experiment showed that a short, online, self-administered growth mindset intervention can increase adolescents’ grades and advanced course-taking, and identified the types of school that were poised to benefit the most.
The scope of mental health research during the COVID-19 pandemic and its aftermath
The effects of the COVID-19 pandemic on population mental health are unknown. We need to understand the scale of any such impact in different sections of the population, who is most affected and how best to mitigate, prevent and treat any excess morbidity. We propose a coordinated and interdisciplinary mental health science response.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Rationale Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. Objectives Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. Methods Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant major depression received two oral doses of psilocybin (10 and 25 mg, 7 days apart) in a supportive setting. Depressive symptoms were assessed from 1 week to 6 months post-treatment, with the self-rated QIDS-SR16 as the primary outcome measure. Results Treatment was generally well tolerated. Relative to baseline, marked reductions in depressive symptoms were observed for the first 5 weeks post-treatment (Cohen’s d  = 2.2 at week 1 and 2.3 at week 5, both p  < 0.001); nine and four patients met the criteria for response and remission at week 5. Results remained positive at 3 and 6 months (Cohen’s d  = 1.5 and 1.4, respectively, both p  < 0.001). No patients sought conventional antidepressant treatment within 5 weeks of psilocybin. Reductions in depressive symptoms at 5 weeks were predicted by the quality of the acute psychedelic experience. Conclusions Although limited conclusions can be drawn about treatment efficacy from open-label trials, tolerability was good, effect sizes large and symptom improvements appeared rapidly after just two psilocybin treatment sessions and remained significant 6 months post-treatment in a treatment-resistant cohort. Psilocybin represents a promising paradigm for unresponsive depression that warrants further research in double-blind randomised control trials.
Abuse, self-harm and suicidal ideation in the UK during the COVID-19 pandemic
This study explored patterns of abuse, self-harm and thoughts of suicide/self-harm in the UK during the first month of the COVID-19 pandemic using data from the COVID-19 Social Study (n=44 775), a non-probability sample weighted to population proportions. The reported frequency of abuse, self-harm and thoughts of suicide/self-harm was higher among women, Black, Asian and minority ethnic (BAME) groups and people experiencing socioeconomic disadvantage, unemployment, disability, chronic physical illnesses, mental disorders and COVID-19 diagnosis. Psychiatric medications were the most common type of support being used, but fewer than half of those affected were accessing formal or informal support.
Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10–24 years): a scoping review
Background Mental health disorders such as high levels of anxiety, isolation, depression and suicide ideation reported among young people living with HIV (10–24 years;YPLHIV) contribute significantly to poor medication adherence and retention in care. While there is evidence supporting the role of psychosocial support interventions in promoting adherence and retention in antiretroviral treatment (ART) among adults living with HIV, there is little evidence on the role of psychosocial support on medication adherence among YPLHIV. This scoping review was designed to identify and classify the types and effects of psychosocial support interventions designed to improve adherence and retention in ART among YPLHIV globally. Method We searched six electronic databases (i.e., Scopus, Pubmed and EBSCOHost (Academic Search Premier, CINAHL, Psycarticles and Medline). Six relevant articles published between 2011 and 2019 met our inclusion criteria. We extracted information relevant to the nature and outcomes of the reported interventions using thematic content analysis informed by the Population, Intervention, comparison, outcome, and time (PICOT) framework. Results Four distinctive treatment modalities that focused on improving ART adherence and retention in care were identified: individual counselling, support groups, family-centered services, and treatment supporters. Conclusion There is a dearth of psychosocial support interventions to improve adherence and retention in ART amongst adolescents and young adults living with HIV. Future research and programming should seek to address psychosocial support interventions or approaches specifically designed to address the needs of YPLHIV. Trial registration PROSPERO: Registration CRD42018105057 .
Effect of depression, anxiety, and distress screeners on the need, intention, and utilization of psychosocial support services among cancer patients
Purpose In clinical cancer care, distress screening is recommended to identify highly burdened patients in objective need for psychosocial support to improve psychological distress and quality of life and to enhance patient empowerment. It is however unclear whether distress screeners are suitable for psychosocial care planning and thus whether they can predict the willingness that is need , intention , and utilization , to seek psychosocial support. Methods In a secondary analysis of a cluster intervention study, we assessed cancer patients with three distress screeners (DT, PHQ-9, GAD-7) at baseline. The willingness to seek psychosocial support services was assessed binary for psychosocial services at 3 and 6 months. Logistic regression models were applied to examine the predictive effect of the screeners on need, intention, and utilization. We corrected all models for multiple testing. Results The 660 patients included in the study were on average 60 years, 54% were male. At the 3- and 6-month follow-up, 353 and 259 patients participated, respectively. The screeners were best in predicting the need for support (OR reaching up to 1.15, 1.20, and 1.22 for the PHQ-9, GAD-7, and DT respectively). The intention was predicted by the PHQ-9 and GAD-7, whereas utilization of psychosocial support services was not predicted by the screeners. Conclusion The three distress screeners might be useful in psychosocial care planning, as they are able to predict the need and to some degree the intention to seek psychosocial support. Future research needs to examine potential barriers and supporting factors that may explain utilization of psychosocial support. Trial registration The study was retrospectively registered (2/2021) at ClinicalTrials.gov (number: NCT04749056).